Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Supply, Demand and Key Producers, 2023-2029
Page: 126
Published Date: 02 Sep 2023
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
The global Antisense oligonucleotides (ASO) Drug and siRNA Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Small nucleic acid drugs are short in length and have a base of less than 30 nt. They mainly act on mRNA in cells through the principle of complementary base pairing to regulate protein expression, thereby achieving therapeutic effects. It can be further divided into single-stranded antisense oligonucleotide ASO, and double-stranded nucleotide siRNA.
This report studies the global Antisense oligonucleotides (ASO) Drug and siRNA Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Antisense oligonucleotides (ASO) Drug and siRNA Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Antisense oligonucleotides (ASO) Drug and siRNA Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Antisense oligonucleotides (ASO) Drug and siRNA Drug total production and demand, 2018-2029, (K Units)
Global Antisense oligonucleotides (ASO) Drug and siRNA Drug total production value, 2018-2029, (USD Million)
Global Antisense oligonucleotides (ASO) Drug and siRNA Drug production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Antisense oligonucleotides (ASO) Drug and siRNA Drug consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Antisense oligonucleotides (ASO) Drug and siRNA Drug domestic production, consumption, key domestic manufacturers and share
Global Antisense oligonucleotides (ASO) Drug and siRNA Drug production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Antisense oligonucleotides (ASO) Drug and siRNA Drug production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Antisense oligonucleotides (ASO) Drug and siRNA Drug production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Antisense oligonucleotides (ASO) Drug and siRNA Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Alnylam, Ionis, Biogen, Novartis, Sarepta Therapeutics, Therapeutics, Akcea, WAVElife and ProQR, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Antisense oligonucleotides (ASO) Drug and siRNA Drug market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market, Segmentation by Type
Antisense Oligonucleotides (ASO) Drug
siRNA Drug
Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market, Segmentation by Application
Single Gene Rare Disease
Protein Deposition Disease
Chronic Liver Disease
Others
Companies Profiled:
Alnylam
Ionis
Biogen
Novartis
Sarepta Therapeutics
Therapeutics
Akcea
WAVElife
ProQR
Exicure
Secarna
AstraZeneca
The WhiteOak Group, Inc.
Dicerna
Silence
Arrowhead
Miragen Therapeutics
Genzyme
Quark Pharmaceuticals
Sylentis
Avidity Biosciences
Key Questions Answered
1. How big is the global Antisense oligonucleotides (ASO) Drug and siRNA Drug market?
2. What is the demand of the global Antisense oligonucleotides (ASO) Drug and siRNA Drug market?
3. What is the year over year growth of the global Antisense oligonucleotides (ASO) Drug and siRNA Drug market?
4. What is the production and production value of the global Antisense oligonucleotides (ASO) Drug and siRNA Drug market?
5. Who are the key producers in the global Antisense oligonucleotides (ASO) Drug and siRNA Drug market?
Table of Contents
1 Supply Summary
1.1 Antisense oligonucleotides (ASO) Drug and siRNA Drug Introduction
1.2 World Antisense oligonucleotides (ASO) Drug and siRNA Drug Supply & Forecast
1.2.1 World Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Value (2018 & 2022 & 2029)
1.2.2 World Antisense oligonucleotides (ASO) Drug and siRNA Drug Production (2018-2029)
1.2.3 World Antisense oligonucleotides (ASO) Drug and siRNA Drug Pricing Trends (2018-2029)
1.3 World Antisense oligonucleotides (ASO) Drug and siRNA Drug Production by Region (Based on Production Site)
1.3.1 World Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Value by Region (2018-2029)
1.3.2 World Antisense oligonucleotides (ASO) Drug and siRNA Drug Production by Region (2018-2029)
1.3.3 World Antisense oligonucleotides (ASO) Drug and siRNA Drug Average Price by Region (2018-2029)
1.3.4 North America Antisense oligonucleotides (ASO) Drug and siRNA Drug Production (2018-2029)
1.3.5 Europe Antisense oligonucleotides (ASO) Drug and siRNA Drug Production (2018-2029)
1.3.6 China Antisense oligonucleotides (ASO) Drug and siRNA Drug Production (2018-2029)
1.3.7 Japan Antisense oligonucleotides (ASO) Drug and siRNA Drug Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Antisense oligonucleotides (ASO) Drug and siRNA Drug Major Market Trends
2.1 World Antisense oligonucleotides (ASO) Drug and siRNA Drug Demand (2018-2029)
2.2 World Antisense oligonucleotides (ASO) Drug and siRNA Drug Consumption by Region
2.2.1 World Antisense oligonucleotides (ASO) Drug and siRNA Drug Consumption by Region (2018-2023)
2.2.2 World Antisense oligonucleotides (ASO) Drug and siRNA Drug Consumption Forecast by Region (2024-2029)
2.3 United States Antisense oligonucleotides (ASO) Drug and siRNA Drug Consumption (2018-2029)
2.4 China Antisense oligonucleotides (ASO) Drug and siRNA Drug Consumption (2018-2029)
2.5 Europe Antisense oligonucleotides (ASO) Drug and siRNA Drug Consumption (2018-2029)
2.6 Japan Antisense oligonucleotides (ASO) Drug and siRNA Drug Consumption (2018-2029)
2.7 South Korea Antisense oligonucleotides (ASO) Drug and siRNA Drug Consumption (2018-2029)
2.8 ASEAN Antisense oligonucleotides (ASO) Drug and siRNA Drug Consumption (2018-2029)
2.9 India Antisense oligonucleotides (ASO) Drug and siRNA Drug Consumption (2018-2029)
3.1 World Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Value by Manufacturer (2018-2023)
3.2 World Antisense oligonucleotides (ASO) Drug and siRNA Drug Production by Manufacturer (2018-2023)
3.3 World Antisense oligonucleotides (ASO) Drug and siRNA Drug Average Price by Manufacturer (2018-2023)
3.4 Antisense oligonucleotides (ASO) Drug and siRNA Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Antisense oligonucleotides (ASO) Drug and siRNA Drug in 2022
3.5.3 Global Concentration Ratios (CR8) for Antisense oligonucleotides (ASO) Drug and siRNA Drug in 2022
3.6 Antisense oligonucleotides (ASO) Drug and siRNA Drug Market: Overall Company Footprint Analysis
3.6.1 Antisense oligonucleotides (ASO) Drug and siRNA Drug Market: Region Footprint
3.6.2 Antisense oligonucleotides (ASO) Drug and siRNA Drug Market: Company Product Type Footprint
3.6.3 Antisense oligonucleotides (ASO) Drug and siRNA Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4.1 United States VS China: Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Value Comparison
4.1.1 United States VS China: Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Comparison
4.2.1 United States VS China: Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Antisense oligonucleotides (ASO) Drug and siRNA Drug Consumption Comparison
4.3.1 United States VS China: Antisense oligonucleotides (ASO) Drug and siRNA Drug Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Antisense oligonucleotides (ASO) Drug and siRNA Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Antisense oligonucleotides (ASO) Drug and siRNA Drug Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Antisense oligonucleotides (ASO) Drug and siRNA Drug Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Value (2018-2023)
4.4.3 United States Based Manufacturers Antisense oligonucleotides (ASO) Drug and siRNA Drug Production (2018-2023)
4.5 China Based Antisense oligonucleotides (ASO) Drug and siRNA Drug Manufacturers and Market Share
4.5.1 China Based Antisense oligonucleotides (ASO) Drug and siRNA Drug Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Value (2018-2023)
4.5.3 China Based Manufacturers Antisense oligonucleotides (ASO) Drug and siRNA Drug Production (2018-2023)
4.6 Rest of World Based Antisense oligonucleotides (ASO) Drug and siRNA Drug Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Antisense oligonucleotides (ASO) Drug and siRNA Drug Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Antisense oligonucleotides (ASO) Drug and siRNA Drug Production (2018-2023)
5.1 World Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Antisense Oligonucleotides (ASO) Drug
5.2.2 siRNA Drug
5.3 Market Segment by Type
5.3.1 World Antisense oligonucleotides (ASO) Drug and siRNA Drug Production by Type (2018-2029)
5.3.2 World Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Value by Type (2018-2029)
5.3.3 World Antisense oligonucleotides (ASO) Drug and siRNA Drug Average Price by Type (2018-2029)
6.1 World Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Single Gene Rare Disease
6.2.2 Protein Deposition Disease
6.2.3 Chronic Liver Disease
6.2.4 Others
6.3 Market Segment by Application
6.3.1 World Antisense oligonucleotides (ASO) Drug and siRNA Drug Production by Application (2018-2029)
6.3.2 World Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Value by Application (2018-2029)
6.3.3 World Antisense oligonucleotides (ASO) Drug and siRNA Drug Average Price by Application (2018-2029)
7.1 Alnylam
7.1.1 Alnylam Details
7.1.2 Alnylam Major Business
7.1.3 Alnylam Antisense oligonucleotides (ASO) Drug and siRNA Drug Product and Services
7.1.4 Alnylam Antisense oligonucleotides (ASO) Drug and siRNA Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Alnylam Recent Developments/Updates
7.1.6 Alnylam Competitive Strengths & Weaknesses
7.2 Ionis
7.2.1 Ionis Details
7.2.2 Ionis Major Business
7.2.3 Ionis Antisense oligonucleotides (ASO) Drug and siRNA Drug Product and Services
7.2.4 Ionis Antisense oligonucleotides (ASO) Drug and siRNA Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Ionis Recent Developments/Updates
7.2.6 Ionis Competitive Strengths & Weaknesses
7.3 Biogen
7.3.1 Biogen Details
7.3.2 Biogen Major Business
7.3.3 Biogen Antisense oligonucleotides (ASO) Drug and siRNA Drug Product and Services
7.3.4 Biogen Antisense oligonucleotides (ASO) Drug and siRNA Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Biogen Recent Developments/Updates
7.3.6 Biogen Competitive Strengths & Weaknesses
7.4 Novartis
7.4.1 Novartis Details
7.4.2 Novartis Major Business
7.4.3 Novartis Antisense oligonucleotides (ASO) Drug and siRNA Drug Product and Services
7.4.4 Novartis Antisense oligonucleotides (ASO) Drug and siRNA Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Novartis Recent Developments/Updates
7.4.6 Novartis Competitive Strengths & Weaknesses
7.5 Sarepta Therapeutics
7.5.1 Sarepta Therapeutics Details
7.5.2 Sarepta Therapeutics Major Business
7.5.3 Sarepta Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Product and Services
7.5.4 Sarepta Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Sarepta Therapeutics Recent Developments/Updates
7.5.6 Sarepta Therapeutics Competitive Strengths & Weaknesses
7.6 Therapeutics
7.6.1 Therapeutics Details
7.6.2 Therapeutics Major Business
7.6.3 Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Product and Services
7.6.4 Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Therapeutics Recent Developments/Updates
7.6.6 Therapeutics Competitive Strengths & Weaknesses
7.7 Akcea
7.7.1 Akcea Details
7.7.2 Akcea Major Business
7.7.3 Akcea Antisense oligonucleotides (ASO) Drug and siRNA Drug Product and Services
7.7.4 Akcea Antisense oligonucleotides (ASO) Drug and siRNA Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Akcea Recent Developments/Updates
7.7.6 Akcea Competitive Strengths & Weaknesses
7.8 WAVElife
7.8.1 WAVElife Details
7.8.2 WAVElife Major Business
7.8.3 WAVElife Antisense oligonucleotides (ASO) Drug and siRNA Drug Product and Services
7.8.4 WAVElife Antisense oligonucleotides (ASO) Drug and siRNA Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 WAVElife Recent Developments/Updates
7.8.6 WAVElife Competitive Strengths & Weaknesses
7.9 ProQR
7.9.1 ProQR Details
7.9.2 ProQR Major Business
7.9.3 ProQR Antisense oligonucleotides (ASO) Drug and siRNA Drug Product and Services
7.9.4 ProQR Antisense oligonucleotides (ASO) Drug and siRNA Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 ProQR Recent Developments/Updates
7.9.6 ProQR Competitive Strengths & Weaknesses
7.10 Exicure
7.10.1 Exicure Details
7.10.2 Exicure Major Business
7.10.3 Exicure Antisense oligonucleotides (ASO) Drug and siRNA Drug Product and Services
7.10.4 Exicure Antisense oligonucleotides (ASO) Drug and siRNA Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Exicure Recent Developments/Updates
7.10.6 Exicure Competitive Strengths & Weaknesses
7.11 Secarna
7.11.1 Secarna Details
7.11.2 Secarna Major Business
7.11.3 Secarna Antisense oligonucleotides (ASO) Drug and siRNA Drug Product and Services
7.11.4 Secarna Antisense oligonucleotides (ASO) Drug and siRNA Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Secarna Recent Developments/Updates
7.11.6 Secarna Competitive Strengths & Weaknesses
7.12 AstraZeneca
7.12.1 AstraZeneca Details
7.12.2 AstraZeneca Major Business
7.12.3 AstraZeneca Antisense oligonucleotides (ASO) Drug and siRNA Drug Product and Services
7.12.4 AstraZeneca Antisense oligonucleotides (ASO) Drug and siRNA Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 AstraZeneca Recent Developments/Updates
7.12.6 AstraZeneca Competitive Strengths & Weaknesses
7.13 The WhiteOak Group, Inc.
7.13.1 The WhiteOak Group, Inc. Details
7.13.2 The WhiteOak Group, Inc. Major Business
7.13.3 The WhiteOak Group, Inc. Antisense oligonucleotides (ASO) Drug and siRNA Drug Product and Services
7.13.4 The WhiteOak Group, Inc. Antisense oligonucleotides (ASO) Drug and siRNA Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 The WhiteOak Group, Inc. Recent Developments/Updates
7.13.6 The WhiteOak Group, Inc. Competitive Strengths & Weaknesses
7.14 Dicerna
7.14.1 Dicerna Details
7.14.2 Dicerna Major Business
7.14.3 Dicerna Antisense oligonucleotides (ASO) Drug and siRNA Drug Product and Services
7.14.4 Dicerna Antisense oligonucleotides (ASO) Drug and siRNA Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Dicerna Recent Developments/Updates
7.14.6 Dicerna Competitive Strengths & Weaknesses
7.15 Silence
7.15.1 Silence Details
7.15.2 Silence Major Business
7.15.3 Silence Antisense oligonucleotides (ASO) Drug and siRNA Drug Product and Services
7.15.4 Silence Antisense oligonucleotides (ASO) Drug and siRNA Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Silence Recent Developments/Updates
7.15.6 Silence Competitive Strengths & Weaknesses
7.16 Arrowhead
7.16.1 Arrowhead Details
7.16.2 Arrowhead Major Business
7.16.3 Arrowhead Antisense oligonucleotides (ASO) Drug and siRNA Drug Product and Services
7.16.4 Arrowhead Antisense oligonucleotides (ASO) Drug and siRNA Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Arrowhead Recent Developments/Updates
7.16.6 Arrowhead Competitive Strengths & Weaknesses
7.17 Miragen Therapeutics
7.17.1 Miragen Therapeutics Details
7.17.2 Miragen Therapeutics Major Business
7.17.3 Miragen Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Product and Services
7.17.4 Miragen Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Miragen Therapeutics Recent Developments/Updates
7.17.6 Miragen Therapeutics Competitive Strengths & Weaknesses
7.18 Genzyme
7.18.1 Genzyme Details
7.18.2 Genzyme Major Business
7.18.3 Genzyme Antisense oligonucleotides (ASO) Drug and siRNA Drug Product and Services
7.18.4 Genzyme Antisense oligonucleotides (ASO) Drug and siRNA Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 Genzyme Recent Developments/Updates
7.18.6 Genzyme Competitive Strengths & Weaknesses
7.19 Quark Pharmaceuticals
7.19.1 Quark Pharmaceuticals Details
7.19.2 Quark Pharmaceuticals Major Business
7.19.3 Quark Pharmaceuticals Antisense oligonucleotides (ASO) Drug and siRNA Drug Product and Services
7.19.4 Quark Pharmaceuticals Antisense oligonucleotides (ASO) Drug and siRNA Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.19.5 Quark Pharmaceuticals Recent Developments/Updates
7.19.6 Quark Pharmaceuticals Competitive Strengths & Weaknesses
7.20 Sylentis
7.20.1 Sylentis Details
7.20.2 Sylentis Major Business
7.20.3 Sylentis Antisense oligonucleotides (ASO) Drug and siRNA Drug Product and Services
7.20.4 Sylentis Antisense oligonucleotides (ASO) Drug and siRNA Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.20.5 Sylentis Recent Developments/Updates
7.20.6 Sylentis Competitive Strengths & Weaknesses
7.21 Avidity Biosciences
7.21.1 Avidity Biosciences Details
7.21.2 Avidity Biosciences Major Business
7.21.3 Avidity Biosciences Antisense oligonucleotides (ASO) Drug and siRNA Drug Product and Services
7.21.4 Avidity Biosciences Antisense oligonucleotides (ASO) Drug and siRNA Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.21.5 Avidity Biosciences Recent Developments/Updates
7.21.6 Avidity Biosciences Competitive Strengths & Weaknesses
8.1 Antisense oligonucleotides (ASO) Drug and siRNA Drug Industry Chain
8.2 Antisense oligonucleotides (ASO) Drug and siRNA Drug Upstream Analysis
8.2.1 Antisense oligonucleotides (ASO) Drug and siRNA Drug Core Raw Materials
8.2.2 Main Manufacturers of Antisense oligonucleotides (ASO) Drug and siRNA Drug Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Mode
8.6 Antisense oligonucleotides (ASO) Drug and siRNA Drug Procurement Model
8.7 Antisense oligonucleotides (ASO) Drug and siRNA Drug Industry Sales Model and Sales Channels
8.7.1 Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Model
8.7.2 Antisense oligonucleotides (ASO) Drug and siRNA Drug Typical Customers
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. World Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Value by Region (2018-2023) & (USD Million)
Table 3. World Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Value by Region (2024-2029) & (USD Million)
Table 4. World Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Value Market Share by Region (2018-2023)
Table 5. World Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Value Market Share by Region (2024-2029)
Table 6. World Antisense oligonucleotides (ASO) Drug and siRNA Drug Production by Region (2018-2023) & (K Units)
Table 7. World Antisense oligonucleotides (ASO) Drug and siRNA Drug Production by Region (2024-2029) & (K Units)
Table 8. World Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Market Share by Region (2018-2023)
Table 9. World Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Market Share by Region (2024-2029)
Table 10. World Antisense oligonucleotides (ASO) Drug and siRNA Drug Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Antisense oligonucleotides (ASO) Drug and siRNA Drug Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Antisense oligonucleotides (ASO) Drug and siRNA Drug Major Market Trends
Table 13. World Antisense oligonucleotides (ASO) Drug and siRNA Drug Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Antisense oligonucleotides (ASO) Drug and siRNA Drug Consumption by Region (2018-2023) & (K Units)
Table 15. World Antisense oligonucleotides (ASO) Drug and siRNA Drug Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Antisense oligonucleotides (ASO) Drug and siRNA Drug Producers in 2022
Table 18. World Antisense oligonucleotides (ASO) Drug and siRNA Drug Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Antisense oligonucleotides (ASO) Drug and siRNA Drug Producers in 2022
Table 20. World Antisense oligonucleotides (ASO) Drug and siRNA Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Company Evaluation Quadrant
Table 22. World Antisense oligonucleotides (ASO) Drug and siRNA Drug Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Site of Key Manufacturer
Table 24. Antisense oligonucleotides (ASO) Drug and siRNA Drug Market: Company Product Type Footprint
Table 25. Antisense oligonucleotides (ASO) Drug and siRNA Drug Market: Company Product Application Footprint
Table 26. Antisense oligonucleotides (ASO) Drug and siRNA Drug Competitive Factors
Table 27. Antisense oligonucleotides (ASO) Drug and siRNA Drug New Entrant and Capacity Expansion Plans
Table 28. Antisense oligonucleotides (ASO) Drug and siRNA Drug Mergers & Acquisitions Activity
Table 29. United States VS China Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Antisense oligonucleotides (ASO) Drug and siRNA Drug Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Antisense oligonucleotides (ASO) Drug and siRNA Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Antisense oligonucleotides (ASO) Drug and siRNA Drug Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Market Share (2018-2023)
Table 37. China Based Antisense oligonucleotides (ASO) Drug and siRNA Drug Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Antisense oligonucleotides (ASO) Drug and siRNA Drug Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Market Share (2018-2023)
Table 42. Rest of World Based Antisense oligonucleotides (ASO) Drug and siRNA Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Antisense oligonucleotides (ASO) Drug and siRNA Drug Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Market Share (2018-2023)
Table 47. World Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Antisense oligonucleotides (ASO) Drug and siRNA Drug Production by Type (2018-2023) & (K Units)
Table 49. World Antisense oligonucleotides (ASO) Drug and siRNA Drug Production by Type (2024-2029) & (K Units)
Table 50. World Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Value by Type (2018-2023) & (USD Million)
Table 51. World Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Value by Type (2024-2029) & (USD Million)
Table 52. World Antisense oligonucleotides (ASO) Drug and siRNA Drug Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Antisense oligonucleotides (ASO) Drug and siRNA Drug Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Antisense oligonucleotides (ASO) Drug and siRNA Drug Production by Application (2018-2023) & (K Units)
Table 56. World Antisense oligonucleotides (ASO) Drug and siRNA Drug Production by Application (2024-2029) & (K Units)
Table 57. World Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Value by Application (2018-2023) & (USD Million)
Table 58. World Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Value by Application (2024-2029) & (USD Million)
Table 59. World Antisense oligonucleotides (ASO) Drug and siRNA Drug Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Antisense oligonucleotides (ASO) Drug and siRNA Drug Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Alnylam Basic Information, Manufacturing Base and Competitors
Table 62. Alnylam Major Business
Table 63. Alnylam Antisense oligonucleotides (ASO) Drug and siRNA Drug Product and Services
Table 64. Alnylam Antisense oligonucleotides (ASO) Drug and siRNA Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Alnylam Recent Developments/Updates
Table 66. Alnylam Competitive Strengths & Weaknesses
Table 67. Ionis Basic Information, Manufacturing Base and Competitors
Table 68. Ionis Major Business
Table 69. Ionis Antisense oligonucleotides (ASO) Drug and siRNA Drug Product and Services
Table 70. Ionis Antisense oligonucleotides (ASO) Drug and siRNA Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Ionis Recent Developments/Updates
Table 72. Ionis Competitive Strengths & Weaknesses
Table 73. Biogen Basic Information, Manufacturing Base and Competitors
Table 74. Biogen Major Business
Table 75. Biogen Antisense oligonucleotides (ASO) Drug and siRNA Drug Product and Services
Table 76. Biogen Antisense oligonucleotides (ASO) Drug and siRNA Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Biogen Recent Developments/Updates
Table 78. Biogen Competitive Strengths & Weaknesses
Table 79. Novartis Basic Information, Manufacturing Base and Competitors
Table 80. Novartis Major Business
Table 81. Novartis Antisense oligonucleotides (ASO) Drug and siRNA Drug Product and Services
Table 82. Novartis Antisense oligonucleotides (ASO) Drug and siRNA Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Novartis Recent Developments/Updates
Table 84. Novartis Competitive Strengths & Weaknesses
Table 85. Sarepta Therapeutics Basic Information, Manufacturing Base and Competitors
Table 86. Sarepta Therapeutics Major Business
Table 87. Sarepta Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Product and Services
Table 88. Sarepta Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Sarepta Therapeutics Recent Developments/Updates
Table 90. Sarepta Therapeutics Competitive Strengths & Weaknesses
Table 91. Therapeutics Basic Information, Manufacturing Base and Competitors
Table 92. Therapeutics Major Business
Table 93. Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Product and Services
Table 94. Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Therapeutics Recent Developments/Updates
Table 96. Therapeutics Competitive Strengths & Weaknesses
Table 97. Akcea Basic Information, Manufacturing Base and Competitors
Table 98. Akcea Major Business
Table 99. Akcea Antisense oligonucleotides (ASO) Drug and siRNA Drug Product and Services
Table 100. Akcea Antisense oligonucleotides (ASO) Drug and siRNA Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Akcea Recent Developments/Updates
Table 102. Akcea Competitive Strengths & Weaknesses
Table 103. WAVElife Basic Information, Manufacturing Base and Competitors
Table 104. WAVElife Major Business
Table 105. WAVElife Antisense oligonucleotides (ASO) Drug and siRNA Drug Product and Services
Table 106. WAVElife Antisense oligonucleotides (ASO) Drug and siRNA Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. WAVElife Recent Developments/Updates
Table 108. WAVElife Competitive Strengths & Weaknesses
Table 109. ProQR Basic Information, Manufacturing Base and Competitors
Table 110. ProQR Major Business
Table 111. ProQR Antisense oligonucleotides (ASO) Drug and siRNA Drug Product and Services
Table 112. ProQR Antisense oligonucleotides (ASO) Drug and siRNA Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. ProQR Recent Developments/Updates
Table 114. ProQR Competitive Strengths & Weaknesses
Table 115. Exicure Basic Information, Manufacturing Base and Competitors
Table 116. Exicure Major Business
Table 117. Exicure Antisense oligonucleotides (ASO) Drug and siRNA Drug Product and Services
Table 118. Exicure Antisense oligonucleotides (ASO) Drug and siRNA Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Exicure Recent Developments/Updates
Table 120. Exicure Competitive Strengths & Weaknesses
Table 121. Secarna Basic Information, Manufacturing Base and Competitors
Table 122. Secarna Major Business
Table 123. Secarna Antisense oligonucleotides (ASO) Drug and siRNA Drug Product and Services
Table 124. Secarna Antisense oligonucleotides (ASO) Drug and siRNA Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Secarna Recent Developments/Updates
Table 126. Secarna Competitive Strengths & Weaknesses
Table 127. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 128. AstraZeneca Major Business
Table 129. AstraZeneca Antisense oligonucleotides (ASO) Drug and siRNA Drug Product and Services
Table 130. AstraZeneca Antisense oligonucleotides (ASO) Drug and siRNA Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. AstraZeneca Recent Developments/Updates
Table 132. AstraZeneca Competitive Strengths & Weaknesses
Table 133. The WhiteOak Group, Inc. Basic Information, Manufacturing Base and Competitors
Table 134. The WhiteOak Group, Inc. Major Business
Table 135. The WhiteOak Group, Inc. Antisense oligonucleotides (ASO) Drug and siRNA Drug Product and Services
Table 136. The WhiteOak Group, Inc. Antisense oligonucleotides (ASO) Drug and siRNA Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. The WhiteOak Group, Inc. Recent Developments/Updates
Table 138. The WhiteOak Group, Inc. Competitive Strengths & Weaknesses
Table 139. Dicerna Basic Information, Manufacturing Base and Competitors
Table 140. Dicerna Major Business
Table 141. Dicerna Antisense oligonucleotides (ASO) Drug and siRNA Drug Product and Services
Table 142. Dicerna Antisense oligonucleotides (ASO) Drug and siRNA Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Dicerna Recent Developments/Updates
Table 144. Dicerna Competitive Strengths & Weaknesses
Table 145. Silence Basic Information, Manufacturing Base and Competitors
Table 146. Silence Major Business
Table 147. Silence Antisense oligonucleotides (ASO) Drug and siRNA Drug Product and Services
Table 148. Silence Antisense oligonucleotides (ASO) Drug and siRNA Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Silence Recent Developments/Updates
Table 150. Silence Competitive Strengths & Weaknesses
Table 151. Arrowhead Basic Information, Manufacturing Base and Competitors
Table 152. Arrowhead Major Business
Table 153. Arrowhead Antisense oligonucleotides (ASO) Drug and siRNA Drug Product and Services
Table 154. Arrowhead Antisense oligonucleotides (ASO) Drug and siRNA Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Arrowhead Recent Developments/Updates
Table 156. Arrowhead Competitive Strengths & Weaknesses
Table 157. Miragen Therapeutics Basic Information, Manufacturing Base and Competitors
Table 158. Miragen Therapeutics Major Business
Table 159. Miragen Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Product and Services
Table 160. Miragen Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. Miragen Therapeutics Recent Developments/Updates
Table 162. Miragen Therapeutics Competitive Strengths & Weaknesses
Table 163. Genzyme Basic Information, Manufacturing Base and Competitors
Table 164. Genzyme Major Business
Table 165. Genzyme Antisense oligonucleotides (ASO) Drug and siRNA Drug Product and Services
Table 166. Genzyme Antisense oligonucleotides (ASO) Drug and siRNA Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 167. Genzyme Recent Developments/Updates
Table 168. Genzyme Competitive Strengths & Weaknesses
Table 169. Quark Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 170. Quark Pharmaceuticals Major Business
Table 171. Quark Pharmaceuticals Antisense oligonucleotides (ASO) Drug and siRNA Drug Product and Services
Table 172. Quark Pharmaceuticals Antisense oligonucleotides (ASO) Drug and siRNA Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 173. Quark Pharmaceuticals Recent Developments/Updates
Table 174. Quark Pharmaceuticals Competitive Strengths & Weaknesses
Table 175. Sylentis Basic Information, Manufacturing Base and Competitors
Table 176. Sylentis Major Business
Table 177. Sylentis Antisense oligonucleotides (ASO) Drug and siRNA Drug Product and Services
Table 178. Sylentis Antisense oligonucleotides (ASO) Drug and siRNA Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 179. Sylentis Recent Developments/Updates
Table 180. Avidity Biosciences Basic Information, Manufacturing Base and Competitors
Table 181. Avidity Biosciences Major Business
Table 182. Avidity Biosciences Antisense oligonucleotides (ASO) Drug and siRNA Drug Product and Services
Table 183. Avidity Biosciences Antisense oligonucleotides (ASO) Drug and siRNA Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 184. Global Key Players of Antisense oligonucleotides (ASO) Drug and siRNA Drug Upstream (Raw Materials)
Table 185. Antisense oligonucleotides (ASO) Drug and siRNA Drug Typical Customers
Table 186. Antisense oligonucleotides (ASO) Drug and siRNA Drug Typical Distributors
List of Figure
Figure 1. Antisense oligonucleotides (ASO) Drug and siRNA Drug Picture
Figure 2. World Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Antisense oligonucleotides (ASO) Drug and siRNA Drug Production (2018-2029) & (K Units)
Figure 5. World Antisense oligonucleotides (ASO) Drug and siRNA Drug Average Price (2018-2029) & (US$/Unit)
Figure 6. World Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Value Market Share by Region (2018-2029)
Figure 7. World Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Market Share by Region (2018-2029)
Figure 8. North America Antisense oligonucleotides (ASO) Drug and siRNA Drug Production (2018-2029) & (K Units)
Figure 9. Europe Antisense oligonucleotides (ASO) Drug and siRNA Drug Production (2018-2029) & (K Units)
Figure 10. China Antisense oligonucleotides (ASO) Drug and siRNA Drug Production (2018-2029) & (K Units)
Figure 11. Japan Antisense oligonucleotides (ASO) Drug and siRNA Drug Production (2018-2029) & (K Units)
Figure 12. Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Antisense oligonucleotides (ASO) Drug and siRNA Drug Consumption (2018-2029) & (K Units)
Figure 15. World Antisense oligonucleotides (ASO) Drug and siRNA Drug Consumption Market Share by Region (2018-2029)
Figure 16. United States Antisense oligonucleotides (ASO) Drug and siRNA Drug Consumption (2018-2029) & (K Units)
Figure 17. China Antisense oligonucleotides (ASO) Drug and siRNA Drug Consumption (2018-2029) & (K Units)
Figure 18. Europe Antisense oligonucleotides (ASO) Drug and siRNA Drug Consumption (2018-2029) & (K Units)
Figure 19. Japan Antisense oligonucleotides (ASO) Drug and siRNA Drug Consumption (2018-2029) & (K Units)
Figure 20. South Korea Antisense oligonucleotides (ASO) Drug and siRNA Drug Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Antisense oligonucleotides (ASO) Drug and siRNA Drug Consumption (2018-2029) & (K Units)
Figure 22. India Antisense oligonucleotides (ASO) Drug and siRNA Drug Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Antisense oligonucleotides (ASO) Drug and siRNA Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Antisense oligonucleotides (ASO) Drug and siRNA Drug Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Antisense oligonucleotides (ASO) Drug and siRNA Drug Markets in 2022
Figure 26. United States VS China: Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Antisense oligonucleotides (ASO) Drug and siRNA Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Market Share 2022
Figure 30. China Based Manufacturers Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Market Share 2022
Figure 32. World Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Value Market Share by Type in 2022
Figure 34. Antisense Oligonucleotides (ASO) Drug
Figure 35. siRNA Drug
Figure 36. World Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Market Share by Type (2018-2029)
Figure 37. World Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Value Market Share by Type (2018-2029)
Figure 38. World Antisense oligonucleotides (ASO) Drug and siRNA Drug Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Value Market Share by Application in 2022
Figure 41. Single Gene Rare Disease
Figure 42. Protein Deposition Disease
Figure 43. Chronic Liver Disease
Figure 44. Others
Figure 45. World Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Market Share by Application (2018-2029)
Figure 46. World Antisense oligonucleotides (ASO) Drug and siRNA Drug Production Value Market Share by Application (2018-2029)
Figure 47. World Antisense oligonucleotides (ASO) Drug and siRNA Drug Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. Antisense oligonucleotides (ASO) Drug and siRNA Drug Industry Chain
Figure 49. Antisense oligonucleotides (ASO) Drug and siRNA Drug Procurement Model
Figure 50. Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Model
Figure 51. Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Alnylam Ionis Biogen Novartis Sarepta Therapeutics Therapeutics Akcea WAVElife ProQR Exicure Secarna AstraZeneca The WhiteOak Group, Inc. Dicerna Silence Arrowhead Miragen Therapeutics Genzyme Quark Pharmaceuticals Sylentis Avidity Biosciences
Related Reports
02 Sep 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
